2021
DOI: 10.1155/2021/8846808
|View full text |Cite
|
Sign up to set email alerts
|

Critical Success Factors for Competitive Advantage in Iranian Pharmaceutical Companies: A Comprehensive MCDM Approach

Abstract: The unprecedented COVID-19 outbreak strengthened the critical manifestation of the rapid development vs. survival for pharmaceutical companies, deploying strategic conduct worldwide. This study therefore explores the endogenous relationship among pharmaceutical companies’ manufacturing strategy and their performance indicators within the ambit of creating a long-lasting competitive advantage in turbulent times. Very often, it is not possible to launch a cause-effect relationship between performance and their d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 115 publications
(141 reference statements)
0
5
0
Order By: Relevance
“…In practical terms, activities related to organizational strategy are intended to combine management processes and obtain competitive advantage, thus promoting the exchange of internal and external knowledge and strengthening the dynamics of the business ecosystem (Rua et al, 2023). It is noteworthy that the CFS related to managerial perceptions of strategy and performance indicators have an influence on aspects related to competitive advantage (Yazdi et al, 2021).…”
Section: Creation Of Competitive Advantagementioning
confidence: 99%
“…In practical terms, activities related to organizational strategy are intended to combine management processes and obtain competitive advantage, thus promoting the exchange of internal and external knowledge and strengthening the dynamics of the business ecosystem (Rua et al, 2023). It is noteworthy that the CFS related to managerial perceptions of strategy and performance indicators have an influence on aspects related to competitive advantage (Yazdi et al, 2021).…”
Section: Creation Of Competitive Advantagementioning
confidence: 99%
“…Globally, the unprecedented COVID-19 outbreak reinforced the critical importance of rapid development vs. survival for pharmaceutical companies and had a significant impact on the medical supply chain as well [32,33]. During the COVID-19 outbreak, Govindan et al [34] created a biobjective MILP model for managing medical waste to reduce the overall costs and dangers of the population's exposure to pollution.…”
Section: Literature Reviewmentioning
confidence: 99%
“…In that sense, drug distribution companies are deserving of particular concern and detailed evaluation. More importantly, some papers (Yazdi et al, 2021) identified a set of criteria to measure the performance of the drug makers. However, the performance of PSCs depends on the logistics abilities and performance of the drug distribution companies than other supply chain actors.…”
Section: Fermatean Fuzzy Entropy and Waspas Modelmentioning
confidence: 99%
“…In that sense, drug distribution companies are deserving of particular concern and detailed evaluation. More importantly, some papers (Yazdi et al. , 2021) identified a set of criteria to measure the performance of the drug makers.…”
Section: Literature Reviewmentioning
confidence: 99%